Nomura Asset Management Co. Ltd. boosted its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 9.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 60,130 shares of the real estate investment trust's stock after purchasing an additional 5,290 shares during the quarter. Nomura Asset Management Co. Ltd. owned about 0.13% of National Health Investors worth $4,167,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank bought a new position in shares of National Health Investors during the fourth quarter valued at $42,322,000. Easterly Investment Partners LLC raised its position in shares of National Health Investors by 32.9% in the 4th quarter. Easterly Investment Partners LLC now owns 89,047 shares of the real estate investment trust's stock worth $6,171,000 after acquiring an additional 22,047 shares in the last quarter. Loomis Sayles & Co. L P lifted its stake in shares of National Health Investors by 42.0% in the 4th quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock valued at $44,000 after purchasing an additional 189 shares during the period. JPMorgan Chase & Co. lifted its stake in National Health Investors by 8.2% in the fourth quarter. JPMorgan Chase & Co. now owns 162,148 shares of the real estate investment trust's stock valued at $11,237,000 after buying an additional 12,252 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in National Health Investors by 6.8% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 29,795 shares of the real estate investment trust's stock worth $2,062,000 after acquiring an additional 1,888 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Trading Up 0.1 %
NYSE NHI traded up $0.05 on Thursday, hitting $73.82. The company's stock had a trading volume of 191,025 shares, compared to its average volume of 215,445. The firm has a market cap of $3.37 billion, a P/E ratio of 25.37, a PEG ratio of 4.42 and a beta of 0.79. National Health Investors, Inc. has a 52-week low of $57.80 and a 52-week high of $86.13. The company's 50-day simple moving average is $71.33 and its 200 day simple moving average is $74.08. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.03. The company had revenue of $85.75 million during the quarter, compared to analyst estimates of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. Research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Shareholders of record on Monday, March 31st will be issued a $0.90 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.88%. National Health Investors's dividend payout ratio is currently 115.38%.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. Truist Financial boosted their price objective on National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a report on Wednesday, March 19th. Wedbush reaffirmed an "outperform" rating and set a $88.00 price objective on shares of National Health Investors in a report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, National Health Investors has an average rating of "Hold" and an average target price of $85.50.
View Our Latest Report on National Health Investors
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
